Patient management important for long-term support beyond 5 years in the BTT: republication of the article published in the Japanese Journal of Artificial Organs.

Home management Implantable LVAD Quality of life

Journal

Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs

ISSN: 1619-0904

Titre abrégé: J Artif Organs

Pays: Japan

ID NLM: 9815648

Informations de publication

Date de publication:
29 Mar 2024

Historique:

received: 29 02 2024

accepted: 01 03 2024

medline: 29 3 2024

pubmed: 29 3 2024

entrez: 29 3 2024

Statut: aheadofprint

Résumé

Heart transplantation is considered to be the best treatment for severe heart failure refractory to medical therapy, improving patients' survival and quality of life (QOL). However, the number of donors is smaller than the number of registered applicants for heart transplantation, which increases every year, and the waiting period for heart transplantation has been extended to more than 1700 days by 2022. Since 2011, reimbursement for the implantable left ventricular assist device (iLVAD) was established. The numbers of the iLVAD patients have been increasing year by year. Patients are managed at home with an iLVAD and can live with their families and even return to work, depending on the situation. On the other hand, self-management at home, including caregivers, is important for a safe life. Home management beyond 5 years is becoming more common due to long waiting time for transplant. This article outlines the important aspects of patient management for long-term support. This review was created based on a translation of the Japanese review written in the Japanese Journal of Artificial Organs in 2023 (Vol. 52, No. 1, pp. 62-66), with some modifications.

Identifiants

DOI: 10.1007/s10047-024-01441-3 PMID: 38548928

pubmed: 38548928

doi: 10.1007/s10047-024-01441-3

pii: 10.1007/s10047-024-01441-3

doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

Informations de copyright

Références

The Japanese Society for Heart Transplantation: Japanese Registry for Heart Transplantation, Aug 2022. http://www.jsht.jp/registry/japan/ . Accessed 1 Feb 2023.

The Japanese Association for Thoracic Surgery: J-MACS Statistical Report. 2023. https: //www.jpats.org/society/jmacs/report.html . Accessed 1 Feb 2023.

Mehra MR, Uriel N, Naka Y, et al. Momentum 3 investigators: a fully magnetically levitated left ventricular assist device—final report. N Engl J Med. 2019;380:1618–27.

doi: 10.1056/NEJMoa1900486 pubmed: 30883052

Mehra MR, Naka Y, Uriel N, et al. Momentum 3 investigators: a fully magnetically levitated circulatory pump for advanced heart failure. N Engl J Med. 2017;376:440–50.

doi: 10.1056/NEJMoa1610426 pubmed: 27959709

Moazami N, Milano CA, John R, et al. HeartMate II investigators: pump replacement for left ventricular assist device failure can be done safely and is associated with low mortality. Ann Thorac Surg. 2013;95:500–5.

doi: 10.1016/j.athoracsur.2012.09.011 pubmed: 23261114

Kusne S, Mooney M, Danziger-Isakov L, et al. An ISHLT consensus document for prevention and management strategies for mechanical circulatory support infection. J Heart Lung Transplant. 2017;36:1137–53.

doi: 10.1016/j.healun.2017.06.007 pubmed: 28781010

Mutsuga M, Okumura T, Morimoto R, et al. Impact of an improved driveline management for HeartMate II and HeartMate 3 left ventricular assist devices. Artif Organs. 2023;47:387–95.

doi: 10.1111/aor.14426 pubmed: 36269680

Cannon A, Elliott T, Ballew C, et al. Variability in infection control measures for the percutaneous lead among programs implanting long-term ventricular assist devices in the United States. Prog Transplant. 2012;22:351–9.

doi: 10.7182/pit2012612 pubmed: 23187051

Slaughter MS, Pagani FD, Rogers JG, et al. HeartMate II clinical investigators: clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29:S1-39.

doi: 10.1016/j.healun.2010.01.011 pubmed: 20181499

Kormos RL Holman W Chapter 13: Adverse events and complications of mechanical circulatory support Mechanical circulatory support: a companion to Braunwald’s heart disease editors Kormos RL Miller LW Elsevier Amsterdam 166–82 2012

Frontera JA, Starling R, Cho SM, et al. Risk factors, mortality, and timing of ischemic and hemorrhagic stroke with left ventricular assist devices. J Heart Lung Transplant. 2017;36:673–83.

doi: 10.1016/j.healun.2016.12.010 pubmed: 28110971

Moazami N, Smedira NG, McCarthy PM, et al. Safety and efficacy of intraarterial thrombolysis for perioperative stroke after cardiac operation. Ann Thorac Surg. 2001;72:1933–9.

doi: 10.1016/S0003-4975(01)03030-2 pubmed: 11789774

Kitano T, Sakaguchi M, Yamagami H, et al. Mechanical thrombectomy in acute ischemic stroke patients with left ventricular assist device. J Neurol Sci. 2020;418:117142.

doi: 10.1016/j.jns.2020.117142 pubmed: 32977225

John R, Kamdar F, Eckman P. Lessons learned from experience with over 100 consecutive HeartMate II left ventricular assist devices. Ann Thorac Surg. 2011;92:1593–9.

doi: 10.1016/j.athoracsur.2011.06.081 pubmed: 22051256

Morgan JA, Paone G, Nemeh HW, et al. Gastrointestinal bleeding with the HeartMate II left ventricular assist device. J Heart Lung Transplant. 2012;31:715–8.

doi: 10.1016/j.healun.2012.02.015 pubmed: 22425231

Kushnir VM, Sharma S, Ewald GA, et al. Evaluation of GI bleeding after implantation of left ventricular assist device. Gastrointest Endosc. 2012;75:973–9.

doi: 10.1016/j.gie.2011.12.014 pubmed: 22341716

Imamura T, Kinugawa K, Nitta D, et al. Opening of aortic valve during exercise is key to preventing development of aortic insufficiency during ventricular assist device treatment. ASAIO J. 2015;61:514–9.

doi: 10.1097/MAT.0000000000000247 pubmed: 25955152

Imamura T, Kinugawa K, Nitta D, et al. Advantage of pulsatility in left ventricular reverse remodeling and aortic insufficiency prevention during left ventricular assist device treatment. Circ J. 2015;79:1994–9.

doi: 10.1253/circj.CJ-15-0419 pubmed: 26118343

Sayer G, Sarswat N, Kim GH, et al. The hemodynamic effects of aortic insufficiency in patients supported with continuous-flow left ventricular assist devices. J Card Fail. 2017;23:545–51.

doi: 10.1016/j.cardfail.2017.04.012 pubmed: 28435003

Truby LK, Garan AR, Givens RC, et al. Aortic insufficiency during contemporary left ventricular assist device support: analysis of the INTERMACS registry. JACC Heart Fail. 2018;6:951–60.

doi: 10.1016/j.jchf.2018.07.012 pubmed: 30384913 pmcid: 6217859